J. Argemí

Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
202310 citationsauthor #22
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.
202319 citationsauthor #16
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming
20239 citationsauthor #16
Alcohol use disorder in patients undergoing bariatric surgery is associated with a worse prognosis
20230 citationsauthor #8
Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy.
202314 citationsauthor #6
Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
202327 citationsauthor #9
Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
20239 citationsauthor #12
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses
20237 citationsauthor #25
AKR1B10 as a novel molecular driver of alcohol-associated hepatitis
20230 citationsauthor #5
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure
202314 citationsauthor #2
Quality of life in patients with unresectable hepatocellular carcinoma treated with selective internal radiation therapy (SIRT) and Nivolumab: a sub-analysis of the NASIR-HCC trial
20230 citationsauthor #12
Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma
20230 citationsauthor #55
Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases
20235 citationsauthor #17
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma
202316 citationsauthor #13
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
20232 citationsauthor #1
TARE ought not to borrow future liver function from patients with HCC. But does it?
20230 citationsauthor #2
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
202257 citationsauthor #12
Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies.
202213 citationsauthor #1
Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone
20222 citationsauthor #4
In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis
20227 citationsauthor #4
Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma (HCC) evolves following a differential activation of endoplasmic reticulum stress responses
20221 citationsauthor #9
Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis
20227 citationsauthor #7
A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
20224 citationsauthor #10
Loss of liver function in chronic liver disease: an identity crisis.
202275 citationsauthor #3
Loss of solute carrier family 38 member 4 (SLC38A4) as a driver for the pathogenesis of severe alcoholic hepatitis
20220 citationsauthor #4
Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis
202214 citationsauthor #5
Immunotherapy in HCC—No rush despite the hype
20222 citationsauthor #2
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
202210 citationsauthor #32
Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM
20224 citationsauthor #4
Galectin‐3 is overexpressed in advanced cirrhosis and predicts post‐liver transplant infectious complications
202220 citationsauthor #7
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
20226 citationsauthor #10
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
202239 citationsauthor #2
Plasma angiopoietin 2 as a novel prognostic biomarker in alcohol-related cirrhosis and hepatitis
20223 citationsauthor #2
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis.
202214 citationsauthor #1
Ceramide synthase 6 (CerS6) promotes alcohol-induced fatty liver by promoting metabolic dysfunction and upregulating lipid droplet-associated proteins
20220 citationsauthor #9
JIND: joint integration and discrimination for automated single-cell annotation
20227 citationsauthor #3
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
20227 citationsauthor #10
Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis
202114 citationsauthor #10
Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease
202111 citationsauthor #4
An Experimental DUAL Model of Advanced Liver Damage
202123 citationsauthor #24
Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
202111 citationsauthor #2
SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
202127 citationsauthor #8
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
202154 citationsauthor #8
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis
202189 citationsauthor #12
504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients
20210 citationsauthor #2
Hospital preparedness for mass gathering events and mass casualty incidents in Matera, Italy, European Capital of Culture 2019
20217 citationsauthor #6
Large-scale silane bead-based SARS-CoV-2 testing of a nursing home in Spain identifies a viral reservoir during lockdown period
20210 citationsauthor #16
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
202168 citationsauthor #32
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
202120 citationsauthor #25
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
202116 citationsauthor #2
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
202151 citationsauthor #47
Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.
20216 citationsauthor #9
Alcoholic Hepatitis
20217 citationsauthor #3
Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values
202179 citationsauthor #2
inhibition accelerates NAFLD-associated
20210 citationsauthor #11
Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection
202112 citationsauthor #4
Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis.
202169 citationsauthor #14
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis
20215 citationsauthor #3
Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis
202112 citationsauthor #6
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
202022 citationsauthor #12
Control del riesgo cardiovascular, la enfermedad metabólica y la esteatosis hepática a través del empoderamiento de la salud: una propuesta de futuro.
20201 citationsauthor #2
Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases
202014 citationsauthor #6
Proteostasis improvement in cystic cholangiocytes alleviates endoplasmic reticulum stress and halts polycystic liver disease
20200 citationsauthor #12
Immunophenotyping for Risk Stratification of Patients with COVID-19
20200 citationsauthor #25
Ethical Criteria for the Admission and Management of Patients in the ICU Under Conditions of Limited Medical Resources: A Shared International Proposal in View of the COVID-19 Pandemic
202018 citationsauthor #12
INTEGRATED MULTI-OMICS REVEALS GLUCOSE USE REPROGRAMMING AND IDENTIFIES A NOVEL HEXOKINASE IN ALCOHOLIC HEPATITIS.
202057 citationsauthor #3
Serum transferrin levels reflect hepatocyte nuclear factor 4 alpha activity in the liver
20200 citationsauthor #2
Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH
202020 citationsauthor #16
Immunologic characterization of COVID-19 patients with hematological cancer
202016 citationsauthor #25
Manual Silane magnetic bead-based high throughput protocol for SARS-CoV-2 RNA extraction v2
20201 citationsauthor #5
Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
202021 citationsauthor #1
New COVID-19 diagnostic platform more efficient than commercial PCR test kits
20200 citationsauthor #2
Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation
202074 citationsauthor #15
Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
20200 citationsauthor #20
Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis
20206 citationsauthor #3
Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
202037 citationsauthor #2
Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice[S]
202029 citationsauthor #13
Genome-Wide Effects of Alcohol Use Disorder on Long Non-Coding RNAs and Splicing in Brain and Liver
20200 citationsauthor #4
Manual Silane magnetic bead-based high throughput protocol for SARS-CoV-2 RNA extraction v1
20201 citationsauthor #5
Inhibition of HSP90 and activation of HSF1 diminishes macrophage NLRP3 inflammasome activity in alcoholic liver injury.
202049 citationsauthor #4
Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis.
202026 citationsauthor #6
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
201991 citationsauthor #9
Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis
201911 citationsauthor #2
Hepatocyte–stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids
20192 citationsauthor #1
A novel mouse model of acute-on-chronic cholestatic alcoholic liver disease: A systems biology comparison with human alcoholic hepatitis.
201913 citationsauthor #2
Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
201928 citationsauthor #6
THU-265-In severe alcoholic hepatitis, serum transferrin indicates impaired HNF4a signaling and predicts mortality independently of disease severity
20190 citationsauthor #7
Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non‐alcoholic steatohepatitis
201852 citationsauthor #5
The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life
201820 citationsauthor #2
Obstructive sleep apnea syndrome and growth failure.
201838 citationsauthor #6
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.
2018190 citationsauthor #5
892 - Transcriptional Dysregulation of Inflammatory Gene Networks in Alcoholic Hepatitis is Associated with Genomewide Reconfiguration of Epigenetic States
20181 citationsauthor #4
Identifying New Epigenetic Drivers of Liver Fibrosis
20189 citationsauthor #1
Histopathological and molecular signatures of a mouse model of acute-on-chronic alcoholic liver injury demonstrate concordance with human alcoholic hepatitis.
201819 citationsauthor #10
Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling
201741 citationsauthor #6
ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.
201748 citationsauthor #6
X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver.
201744 citationsauthor #1
Identification of a New Inborn Error in the Peroxisomal Steps of Bile Acid Synthesis Resulting in Accumulation of Toxic Bile Acid Intermediates and Hepatocellular Damage
20165 citationsauthor #13
Liver UPR and Metabolic Consequences in an Animal Model of Intrauterine Growth Retardation (IUGR)
20160 citationsauthor #2
Liver ER Stress and Intrauterine Growth Retardation in Rats
20150 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT